E2F Transcription Factor 6 (E2F6) Antibody

Documentos del producto

Especificaciones del producto

Primary Antibodies

Target: E2F Transcription Factor 6 (E2F6)
Immunogen: Synthesized peptide derived from the Internal region of human E2F-6.

Rabbit

Human, Mouse, Rat

ELISA: 1/20000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/300. Optimal dilutions/concentrations should be determined by the end user.

Polyclonal

Unconjugated

IgG

Purified by affinity chromatography.

50 µg

100 µg

Liquid

ELISA, WB, IHC

PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Shipped within 5-10 working days.

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.

No

O75461

1876

E2F-6

Antibody anti-E2F6

RUO

THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

E2F6 is a unique member of the E2F family that functions primarily as a transcriptional repressor independent of retinoblastoma (RB) proteins. Unlike other E2F family members, E2F6 lacks a transactivation domain and instead represses gene expression through association with polycomb group (PcG) proteins and chromatin-modifying complexes. E2F6 plays a critical role in gene silencing during the G1/S transition and is particularly involved in maintaining transcriptional repression during cell differentiation and development. It regulates genes involved in DNA repair, meiosis, and embryonic patterning by modulating chromatin structure. E2F6 is highly expressed in embryonic stem cells and germ cells, where it prevents aberrant transcription of proliferation-associated genes. Knockout studies reveal defects in meiosis and homeotic gene expression, highlighting its importance in chromatin remodeling, developmental regulation, and transcriptional repression.